Aurora Therapeutics' first target is the rare inherited disease phenylketonuria, also known as PKU. Here at MIT Technology Review we’ve been writing about the gene-editing technology CRISPR since 2013 ...

Scientists and physicians can better assess precision genome editing technology using a new method made public today by St. Jude Children's Research Hospital. Significant amounts of time and resources ...

Scientists and physicians can better assess precision genome editing technology using a new method made public today by St. Jude Children's Research Hospital. Significant amounts of time and resources ...

New panels from LG Display and Samsung Display should have easier-to-read text thanks to vertical RGB stripes. New OLED ...

Cathie Wood’s latest moves entering 2026 focused on early-stage biotechnology firms while cutting exposure to consumer technology, diagnostics and space tech companies. The investment firm added ...

Like other developing countries, Indonesia is facing a familiar dilemma: how to feed a growing population while protecting its extraordinary biodiversity. Subscribe to our newsletter for the latest ...

Beam Therapeutics BEAM is engaged in developing investigational gene therapy candidates that are currently in early-to-mid-stage development for treating certain hematology and genetic diseases. The ...

China’s dairy farms are becoming increasingly green through the development of breeding and reproductive technologies that are helping make farming more sustainable, efficient and productive.

The Atlantic’s Science, Technology, and Health desk has had a busy 2025: Our writers have spent the year probing the limits of human consciousness and gene-editing technology, studying the ubiquity of ...

This year, hype around AI really exploded, and so did concerns about AI’s environmental footprint. We also saw some surprising biotech developments. It's been a busy and productive year here at MIT ...